On November 12, more than 50 managed care professionals and various health care stakeholders gathered in Old Town Alexandria, Virginia to examine these barriers to adoption for RWE in managed care.
Integrated Delivery Network’s Role in Value-Based Agreements for Pharmacy and Medical Benefits Partnership Forum
Implementing value-based reimbursement models for both pharmaceuticals and medical care poses significant challenges and opportunities, and depends on integrated delivery networks (IDNs) to execute the processes and programs. The AMCP Partnership Forum, Integrated Delivery Network’s Role in Value-Based Agreements for Pharmacy and Medical Benefits, took place on Nov. 13-14, 2018 in Arlington, VA.
Value-based care models are designed to support payment based on improved outcomes rather than volume of care provided. AMCP has taken a leading role in advancing the concept, which has potential to improve quality of patient care and lower costs. Previous Partnership Forums have examined different aspects of value-based care. The November Partnership Forum explored issues around establishing value-based agreements between biopharmaceutical companies and IDNs.
The event was made possible with support from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Lilly, MedImpact, Merck, National Pharmaceutical Council, Novo Nordisk, the Pharmaceutical Research and Manufacturers of America, Takeda, and Xcenda.
Additional Materials:
Related
Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
This advisory group was active from March 2021-June 2022.
Featured News & Resources
See Full Calendar
Other Events
HBCU Travel Awards for AMCP25
Other Events
Mid-South AMCP Day of Education 2025
Other Events
Southwest AMCP Annual Day of Education 2025
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
